Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
IPO Date: April 2, 1991
Sector: Healthcare
Industry: Biotech
Market Cap: $59.16B
Activated in VL: True
Average Daily Range
Avg Daily Range: $4.24 | 1.81%
Avg Daily Range (30 D): $7.61 | 1.42%
Avg Daily Range (90 D): $9.70 | 1.70%
Institutional Daily Volume
Avg Daily Volume: .66M
Avg Daily Volume (30 D): .82M
Avg Daily Volume (90 D): .98M
Trade Size
Avg Trade Size (Sh.): 64
Avg Trade Size (Sh.) (30 D): 27
Avg Trade Size (Sh.) (90 D): 29
Institutional Trades
Total Inst.Trades: 11,115
Avg Inst. Trade: $18M
Avg Inst. Trade (30 D): $33.84M
Avg Inst. Trade (90 D): $40.08M
Avg Inst. Trade Volume: .05M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $35.66M
Avg Closing Trade (30 D): $76.79M
Avg Closing Trade (90 D): $90.31M
Avg Closing Volume: 72.44K
   
News
Jul 19, 2025 @ 10:09 AM
After Falling 68%, Where Will This Weight-Loss Dru...
Source: James Brumley
Jul 14, 2025 @ 8:47 AM
Wet Age-Related Macular Degeneration (Wet AMD) Mar...
Source: Researchandmarkets.Com
Jun 20, 2025 @ 2:47 PM
FDA Approves Regeneron Sanofi Treatment For Rare A...
Source: Vandana Singh
Jun 15, 2025 @ 3:22 PM
Press Release: EAACI: Dupixent demonstrated superi...
Source: N/A
Jun 15, 2025 @ 3:22 PM
Communiqué : Dupixent a démontré sa supÃ...
Source: N/A
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $41.77 $7.58 $8.54
Diluted EPS $39.33 $7.27 $8.11
Revenue $ 14.09B $ 3.03B $ 3.79B
Gross Profit $ $ $
Net Income / Loss $ 4.5B $ 808.7M $ 917.7M
Operating Income / Loss $ 3.83B $ 591.7M $ 990.2M
Cost of Revenue $ $ $
Net Cash Flow $ 483.2M $ 604M $ 477.2M
PE Ratio 14.51